INS and colorectal carcinoma: It has been documented that exogenous insulin used for insulin-dependent diabetes elevates the risk of CRC via overstimulation of insulin-like growth factor receptor 1 (IGF-1R) in the intestinal epithelium, leading to proliferation and cell survival [9].